Delivery Order SPE2DB22D1002-SPE2DB25FLHB0
- Not listed
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This firm fixed price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania location with an ultimate completion date of October 7, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The contract is set to be completed by October 14, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 22, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. This $6,165.34 firm fixed price delivery order is scheduled for completion by September 3, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injectors valued at $12,330.68 with a firm fixed price structure. This non-set-aside contract is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $15,407.08 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on September 12, 2025, with a completion date of October 3, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Benlysta 200 mg/mL auto-injector units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on September 5, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of September 26, 2025. The award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector, with an ultimate completion date of October 3, 2025. This non-competitive, firm fixed-price delivery order was issued on September 12, 2025, under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHB0Delivery Order
The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Benlysta 200 mg/mL auto-injectors, with a completion date of September 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, supplying a broad range of medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill federal requirements across multiple therapeutic domains, including specialty medications and medical devices. This delivery order for Benlysta, a biologic treatment for systemic lupus erythematosus, reflects the contractor's ongoing role in supporting military medical needs through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/29/25 |